These gliomas almost universally have unmethylated O6-methylguanine-DNA-methyltransferase (MGMT) promoter (9, 10) and generally do not respond to the oral alkylating agent temozolomide (TMZ) (11, 12), with a dismal prognosis (13–17). Here, MGMT is linked to central nervous system cancer.